References
- Moyle G, the APPT-1 Study Team. The Assessing Patients’ Preferred Treatments (APTT-1) study. Int J of STD & AIDS 2003;14(Suppl 1):34–6.
- Weber R, Christen L, Christen S, Tschopp S, Znoj H, Schneider C, et al. Effect of individual cognitive behaviour intervention on adherence to antiretroviral therapy: prospective randomized trial. Antivir Ther 2004; 9: 85–95
- Staszewski S, Morales-Ramirez J, Tashima KT, Rachlis A, Skiest D, Stanford J, et al. Efavirenz plus zidovudine and lamivudine, efavirenz plus indinavir, and indinavir plus zidovudine and lamivudine in the treatment of HIV-1 infection in adults. N Engl J Med 1999; 341: 1865–73
- Haas D, Ribaudo H, Kim RB, Tierney C, Wilkinson GR, Gulick R, et al. Pharmacogenetics of efavirenz and central nervous system side-effects: an Adult AIDS Clinical Trials Group study. AIDS 2004; 18: 2391–400